Company Filing History:

10 out of 10,754

Basf Aktiengesellschaft

patents

3 out of 4,177

Abbott Laboratories Corporation

patents

Years Active: 1992-2002

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6414157 - 3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use (2002-07-02),

2. 6387912 - Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia (2002-05-14),

3. 6355647 - 3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use (2002-03-12),

4. 6346622 - 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5HT1B and 5-HT1D) (2002-02-12),

5. 6222034 - 3-substituted pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use (2001-04-24),

6. 6159981 - 3-substituted pyrido [3',4':4,5] Thieno [2,3-d] pyrimidine derivatives, (2000-12-12),

7. 6159962 - 3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and (2000-12-11),

8. 615996 - 3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and (2000-12-12),

9. 5831002 - Antitumor peptides (1998-11-03),

10. 5504189 - Peptides, their preparation and use (1996-04-02),

11. 5231024 - Monoclonal antibodies against human tumor necrosis factor (TNF), and use (1993-07-27),

12. 5180811 - Proteins having a TNF action comprising TNF-fibromectin fusion protein (1993-01-19),

13. 5157106 - N-terminal deletions of lymphotoxin, their preparation and use (1992-10-20),

Title: Franz Emling: Innovator in Pharmaceutical Chemistry

Introduction

Franz Emling is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on drug development. With a total of 13 patents to his name, Emling has established himself as a key figure in the industry.

Latest Patents

Among his latest patents, Emling has developed 3-Substituted tetrahydropyridopyrimidinone derivatives, which include methods for producing these compounds and their applications in creating active ingredients for drugs. These derivatives are characterized by specific radicals as detailed in the patent description. Additionally, he has worked on the utilization of pyrimidine derivatives for preventing and treating cerebral ischemia, showcasing his focus on addressing critical health issues.

Career Highlights

Emling's career has been marked by his association with prominent companies in the pharmaceutical sector. He has worked with BASF Aktiengesellschaft and Abbott Laboratories Corporation, where he has contributed to various research and development projects. His expertise in the field has allowed him to make impactful advancements in drug formulation and therapeutic applications.

Collaborations

Throughout his career, Emling has collaborated with esteemed colleagues, including Gerd Steiner and Dorothea Starck. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Franz Emling's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic solutions, making him a significant figure in the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.